J&J Ebola vaccine gets 100 million euros to speed development

January 16, 2015 1:02 PM

16 0

LONDON (Reuters) - Johnson & Johnson said on Friday that newly formed groups supporting work on its experimental Ebola vaccine would receive 100 million euros ($115 million) from Europe's Innovative Medicines Initiative to speed development.

The U.S. drugmaker earlier this month announced it had started clinical trials of its two-injection vaccine, which uses a booster from Denmark's Bavarian Nordic, making it the third such product to enter human testing.

Read more

To category page